Women who use Depo-Provera or other hormonal birth control pills face a higher risk of developing a slow-growing rare brain ...

Pfizer is undervalued, trading just over 8x 2026 earnings, with improving dividend yield and core business fundamentals.

So far, Pfizer has been an also-ran in the GLP-1 race, but that could change if its long-acting weight-loss medication takes ...

When two steel columns buckled this week inside the former Pfizer headquarters in midtown Manhattan, the scare prompted ...

McDonald's and Pfizer are blue-chip laggards trading at a discount, and both promise retirees a place to park serious money.

Abrocitinib can help achieve minimal disease activity in patients with atopic dermatitis irrespective of previous exposure to ...

Income investors watching the calendar have a narrow window this week. Three of the market’s most widely held high-yield ...

A KC surgeon's efforts to enforce 18 of his patents could lead to him seeing his longtime attorneys booted from the case.

Following the partial floor cave-in of the old Pfizer building in Midtown on Tuesday, the developer working to convert the ...

Pfizer noted that preserving and supporting its dividend is a priority as recently as its first-quarter 2026 earnings call in ...

As U.S. lawmakers continue to scrutinize the consequences of China’s expanding role in biotech innovation, industry insiders ...

The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.